Bayer wins US approval for potential blockbuster stroke drug

Summary
The Food and Drug Administration approved asundexian to prevent additional strokes in people who already have suffered one.
Description from The Seattle Times.
Who is covering this
-
Bayer wins US approval for potential blockbuster stroke drug
The Food and Drug Administration approved asundexian to prevent additional strokes in people who already have suffered one.






Comments
Comments need JavaScript.